Enveda Biosciences secures $55m to advance AI-driven drug discovery
Enveda Biosciences, a leader in utilizing artificial intelligence (AI) to convert nature’s chemistry into groundbreaking medicines, has successfully raised an additional $55 million. This funding round is an addition to a previously raised $119 million combined in Series B and B1, bringing significant new investors on board, including Premji Invest, Lingotto Investment Fund, Microsoft, and […]